AI assistant
Telix Pharmaceuticals Ltd — Share Issue/Capital Change 2024
Mar 26, 2024
31324_rns_2024-03-26_bcd10c3e-99d6-4d59-aea8-2819a983b89b.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Announcement Summary
Entity name
TELIX PHARMACEUTICALS LIMITED
Date of this announcement
Wednesday March 27, 2024
The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
Total number of +securities to be issued/transferred
| Total number of | |||
|---|---|---|---|
| ASX +security | +securities to be | ||
| code | Security description | issued/transferred | Issue date |
| New class - code | Performance share incentive rights | 440,000 | 25/03/2024 |
| to be confirmed |
Refer to next page for full details of the announcement
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
1 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 1 - Entity and announcement details
1.1 Name of entity
TELIX PHARMACEUTICALS LIMITED
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 Registered number type Registration number ACN 616620369
1.3 ASX issuer code
TLX
1.4 The announcement is
New announcement
1.5 Date of this announcement
27/3/2024
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
2 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 2 - Issue details
2.1 The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
does not have an existing ASX security code ("new class")
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
3 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B
| ASX +security code New class - code to be confirmed |
+Security description Performance share incentive rights |
|---|---|
| +Security type | ISIN code |
| Other |
Date the +securities the subject of this notification were issued 25/3/2024 Will all the +securities issued in this class rank equally in all respects from their issue date? Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate? Yes
Provide details of the KMP or +associates being issued +securities.
| Provide details of the KMP | or +associates being issued +securities. | |
|---|---|---|
| Name of KMP | Name of registered holder | Number of +securities |
| Darren Smith | Darren Smith | 70,000 |
| Richard Valeix | Richard Valeix | 70,000 |
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being issued.
Material terms for Performance Share Incentive Rights (PSIRs) issued during 2024, including performance conditions and weightings, and performance assessment and retrospective disclosure of outcomes to Executive KMP, are detailed in Telix's 2023 Remuneration report, within its 2023 Annual Report - see 2023 Remuneration report section 5.4.2, which can be viewed at https://annualreport.telixpharma.com/2023/.
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms
-
- Refer to Telix's Equity Incentive Plan Rules accessible at https://telixpharma.com/investor centre/corporate governance/
Any other information the entity wishes to provide about the +securities the subject of this notification
PSIRs are being issued under the Company's long-term incentive and retention policy. Telix will satisfy the exercise of the PSIRs from shares held in the Employee Share Trust.
Issue details
Number of +securities
440,000
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
4 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 4 - +Securities on issue
Following the issue, conversion or payment up of the +securities the subject of this application, the +securities of the entity will comprise:
(A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.)
4.1 Quoted +Securities (Total number of each +class of +securities quoted)
| 4.1 Quoted +Securities (Total number of each +class of +securities quoted) | |
|---|---|
| Total number of | |
| ASX +security code and description | +securities on issue |
| TLX : ORDINARY FULLY PAID | 323,989,947 |
| 4.2 Unquoted +Securities (Total number of each +class of +securities issued but | not quoted on ASX) |
| Total number of | |
| ASX +security code and description | +securities on issue |
| TLXAJ : OPTION EXPIRING 30-JUN-2024 EX $1.83 | 63,000 |
| TLXAI : OPTION EXPIRING 12-JAN-2024 EX $2.23 | 435,000 |
| TLXAQ : SHARE RIGHTS EXPIRING 13-JUN-2027 EX NIL | 80,000 |
| TLXAR : PERFORMANCE RIGHTS | 2,523,720 |
| TLXAP : SHARE RIGHTS | 1,247,000 |
| TLXAO : SHARE APPRECIATION RIGHTS | 8,429,996 |
| TLXAH : OPTION EXPIRING 03-NOV-2023 EX $2.30 | 100,000 |
| TLXAM : OPTION EXPIRING 20-JUL-2026 EX $5.37 | 584,992 |
| TLXAN : SHARE RIGHTS EXPIRING 20-JUL-2026 EX NIL | 100,000 |
| TLXAL : OPTION EXPIRING 27-JAN-2026 EX $4.38 | 704,842 |
| New class - code to be confirmed : Performance share incentive rights | 440,000 |
4.2 Unquoted +Securities (Total number of each +class of +securities issued but not quoted on ASX)
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
5 / 6
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
==> picture [21 x 22] intentionally omitted <==
Part 5 - Other Listing Rule requirements
5.1 Were the +securities issued under an exception in Listing Rule 7.2 and therefore the issue did not need any security holder approval under Listing Rule 7.1? Yes
5.1a Select the number of the applicable exception in Listing Rule 7.2
13
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
6 / 6